Influence of abnormal spleen on liver pathophysiological function in patients with liver cirrhosis

Jiang XiaoNi; Liu Min; Li Qiang; Wang YuPing; Guo QingHong; Guan QuanLin; Zhou YongNing

doi:10.3969/j.issn.1001-5256.2018.11.034

Issue 11

Nov. 2018

Turn off MathJax

Article Contents

Article Navigation > Journal of Clinical Hepatology > 2018 > 34(11): 2420-2422

PDF( 1594 KB)

Influence of abnormal spleen on liver pathophysiological function in patients with liver cirrhosis

DOI: 10.3969/j.issn.1001-5256.2018.11.034

Research funding:

Published Date: 2018-11-20

Abstract

Abstract

Splenomegaly is an early sign of cirrhotic portal hypertension. In patients with liver cirrhosis, the resistance of splenic venous reflux increases and portal venous pressure is reversed to the spleen, which causes congestive splenomegaly and hyperplasia of splenic tissue and fibrous tissue. In addition, intestinal antigens enter the systemic circulation via the portal-systemic collateral circulation and stimulates the proliferation of mononuclear macrophages in the spleen after being taken up by the spleen, which further leads to splenomegaly and hypersplenism. On the contrary, abnormal spleen can cause the changes in liver function and portal vein hemodynamics. Therefore, the intervention of the spleen cannot be neglected during the treatment of liver cirrhosis and its complications. This article reviews the influence of abnormal spleen structure and function on liver pathophysiological function in patients with liver cirrhosis.
- liver cirrhosis,
- hypertension, portal,
- splenomegaly,
- hypersplenism,
- review

FullText(HTML)

References(37)

References

[1] MCKENZIE CV, COLONNE CK, YEO JH, et al. Splenomegaly:Pathophysiological bases and therapeutic options[J]. Int J Biochem Cell B, 2018, 94:40-43.

[2] LI H, WANG GS. Research progress in hypersplenism after liver transplantation for liver cirrhosis[J]. Ogran Transplantation, 2016, 7 (3) :238-240. (in Chinese) 李慧, 汪根树.肝硬化肝移植术后脾功能亢进的研究进展[J].器官移植, 2016, 7 (3) :238-240.

[3] OKUDA K, KONG K, OHNISHI K, et al. Clinical study of eightysix caseins of idiopathic portal hypertension and comparison with cirrhosis with splenomegaly[J]. Gasteoenterology, 1984, 86:600-610.

[4] PRESSER N, QUONTINI C, TOM C, et al. Safety and efficacy of splenic artery embolization for portal hyperperfusion in liver transplant recipients:A 5-year experience[J]. Liver Transplant, 2015, 21 (4) :435-441.

[5] LI YN, MIAO XY, QI HZ, et al. Splenic artery trunk embolization reduces the surgical risk of liver transplantation[J]. Hepatobiliary Pancreat Dis Int, 2015, 14 (3) :263-268.

[6] TSOCHATZIS EA, BOSCH J, BURROUGHS AK. Liver cirrhosis[J]. Lancet, 2014, 383 (9930) :1749-1761.

[7] VAIRAPPAN B. Endothelial dysfunction in cirrhosis:Role of inflammation and oxidative stress[J]. World J Hepatol, 2015, 7 (3) :443-459.

[8] BOLOGNESI M, PASCOLI MD, VERARDO A, et al. Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis[J].World J Gastroenterol, 2014, 20 (10) :2555-2563.

[9] NAGASUE N, DHAR DK, YAMANOI A, et al. Production and release of endothelin-1 from the gut and spleen in portal hypertension due to cirrhosis[J]. Hepatology, 2000, 31 (5) :1107-1114.

[10] MITCHELL O, FELDMAN DM, DIAKOW M, et al. The pathophysiology of thrombocytopenia in chronic liver disease[J]. Hepat Med, 2016, 8 (1) :39-50.

[11] HAYASHI H, BEPPU T, SHIRABE K, et al. Management of thrombocytopenia due to liver cirrhosis:A review[J]. World J Gastroenterol, 2014, 20 (10) :2595-2605.

[12] MASSOUD OI, ZEIN NN. The effect of transjugular intrahepatic portosystemic shunt on platelet counts in patients with liver cirrhosis[J].Gastroenterol Hepatol, 2017, 13 (5) :286-291.

[13] CHIEN CH, LIN YL, CHIEN RN, et al. Transient elastography for spleen stiffness measurement in patients with cirrhosis:Role in degree of thrombocytopenia[J]. J Ultras Med, 2016, 35 (9) :1849-1857.

[14] DUBOIS B, WILCOX C, WEINTRAUB J, et al. Efficacy and safety of partial splenic embolization in patients with splenomegaly associated cytopenias[J]. J Vasc Interv Radiol, 2017, 28 (2) :s69-s70.

[15] FEND B, ZHANG W, LUO BF, et al. Effect of spleen operation on antiviral treatment in hepatitis C virus-related cirrhotic patients[J].World J Gastroenterol, 2014, 20 (41) :15387-15397.

[16] PRIMIGNANI M. Portal vein thrombosis, revisited[J]. Digest Liver Dis, 2010, 42:163-170.

[17] QI XS, STEFANO VD. Anticoagulation for thetreatment of portal vein thrombosis in liver cirrhosis:A systematic review and meta-analysis of observational studies[J]. Eur J Intern Med, 2015, 26 (1) :23-29.

[18] PU YS, ZHANG S, ZHOU R, et al. IL-17A up-regulates expression of endothelial tissue factor in liver cirrhosis via the ROS/p38 signal pathway[J]. Biochem Biophys Res Commun, 2016, 470 (1) :41-47.

[19] ORLANDO R, LIRUSSI F, BASSO SM, et al. Splenomegaly as risk factor of liver cirrhosis. A retrospective cohort study of 2, 525patients who underwent laparoscopy[J]. Vivo, 2011, 25 (23) :1009-1012.

[20] WANG LF, SUN Y, ZHANG Z, et al. CXCR5+CD4+T follicular helper cells participate in the pathogenesis of primary biliary cirrhosis[J]. Hepatology, 2015, 61 (2) :627-638.

[21] LI L, DUAN M, CHEN W, et al. The spleen in liver cirrhosis:Revisiting an old enemy with novel targets[J]. J Transl Med, 2017, 15 (1) :111.

[22] ABOU-SHADY M, FRIESS H, ZIMMERMANN A, et al. Connective tissue growth factor in human liver cirrhosis[J]. Liver, 2000, 20 (4) :296-304.

[23] KUROKAWA T, OHKOHCHI N. Platelets in liver disease, cancer and regeneration[J]. World J Gastroenterol, 2017, 23 (18) :3228-3239.

[24] AKAHOSHI T, HASHIZUME M, TANOUE K, et al. Role of the spleen in liver ftbrosis in rats may be mediated by transforming growth factorβ-1[J]. J Gastroen Hepatol, 2002, 17 (1) :59-65.

[25] KONG DG, CHEN XL, LU SC, et al. Short-term effects of splenectomy on serum fibrosis indexes in liver cirrhosis patients[J]. Int J Clin Exp Pathol, 2015, 8 (11) :15260-15264.

[26] KWON YJ, LEE KG, CHOI D. Clinical implications of advances in liver regeneration[J]. Clin Mol Hepatol, 2015, 21 (1) :7-13.

[27] YAMADA S, MORINE Y, IMURA S, et al. Liver regeneration after splenectomy in patients with liver cirrhosis[J]. Hepatol Res, 2016, 46 (5) :443-449.

[28] MEYER J, LEJMI E, FONTANA P, et al. A focus on the role of platelets in liver regeneration:Do platelet-endothelial cell interactions initiate the regenerative process?[J]. J Hepatol, 2015, 63 (5) :1263-1271.

[29] STARLINGER P, ASSINGER A, GRUENBERGER T, et al. The role of platelets and portal venous pressure fluctuations in postoperative liver regeneration[J]. Eur Surg, 2015, 47 (6) :312-318.

[30] UEDA S, YAMANOI A, HISHIKAWA Y, et al. Transforming growth factor-β1 released from the spleen exerts a growth inhibitory effect on liver regeneration in rats[J]. Lab Invest, 2003, 83 (11) :1595-1603.

[31] CARRAPITA J, ARANTES AM, CAMPELOS S, et al. Impact of splenic artery ligation after major hepatectomy on liver function, regeneration and viability[J]. Sci Rep, 2016, 6:34731.

[32] LIU G, XIE C, FANG Y, et al. Splenectomy after partial hepatectomy accelerates liver regeneration in mice by promoting tight junction formation via polarity protein par 3-a PKC[J]. Life Sci, 2018, 192:91-98.

[33] YAMAMOTO N, OKANO K, OSHIMA M, et al. Laparoscopic splenectomy for patients with liver cirrhosis:Improvement of liver function in patients with child-pugh class B[J]. Surgery, 2015, 158 (6) :1538-1544.

[34] CHIN JL, CHAN G, RYAN JD, et al. Spleen stiffness can noninvasively assess resolution of portal hypertension after liver transplantation[J]. Liver Int, 2015, 35 (2) :518-523.

[35] WONG GLH, KWOK R, HUI AJ, et al. A new screening strategy for varices by liver and spleen stiffness measurement (LSSM) in cirrhotic patients:A randomized trial[J]. Liver Int, 2018, 38 (4) :636-644.

[36] SONG JY, DU GS, XIAO L, et al. Individualized immunosuppressive protocol of liver transplant recipient should be made based on splenic function status[J]. Chin Med J, 2016, 129 (11) :1340-1346.

[37] GAO XQ, ZHAO YX, REN X, et al. Research advances in druginduced autoimmune hepatitis[J]. J Clin Hepatol, 2017, 33 (11) :2222-2225. (in Chinese) 高晓琴, 赵永勋, 任茜, 等.药物诱导的自身免疫性肝炎的研究进展[J].临床肝胆病杂志, 2017, 33 (11) :2222-2225.

Relative Articles

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (1450) PDF downloads(338)

Influence of abnormal spleen on liver pathophysiological function in patients with liver cirrhosis

DOI: 10.3969/j.issn.1001-5256.2018.11.034

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Influence of abnormal spleen on liver pathophysiological function in patients with liver cirrhosis

DOI: 10.3969/j.issn.1001-5256.2018.11.034

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content